Publications 2022
Lysa
2022_LYSA_Outcomes of elderly diffuse large B-cell lymphoma patients treated with R-CHOP: 10-year follow-up of the LNH03-6B trial
10.1182/bloodadvances.2022007609.
En savoir plus
Lysa
2022_LYSA_Oncogenetic landscape of lymphomagenesis in coeliac disease
Gut . 2022 Mar;71(3):497-508.
En savoir plus
Lysa
2022_LYSA_PET-driven strategy in advanced Hodgkin lymphoma: prolonged follow-up of the AHL2011 Phase III LYSA study
J Clin Oncol . 2022 Apr 1;40(10):1091-1101.
En savoir plus
Lysa
2022_LYSA_Lenalidomide-induced arthritis: A case report and review of literature and pharmacovigilance databases
J Oncol Pharm Pract . 2022 Mar;28(2):453-456.
En savoir plus
Lysa
2022_LYSA_Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials
Blood . 2022 Mar 17;139(11):1684-1693.
En savoir plus
Lysa
2022_LYSA_A guide to ComBat harmonization of imaging biomarkers in multicenter studies
J Nucl Med . 2022 Feb;63(2):172-179.
En savoir plus
Lysa
2022_LYSA_Deep Learning approach to automatize TMTV calculation regardless of segmentation methodology for main FDG avid lymphomas
Diagnostics (Basel) . 2022 Feb 6;12(2):417.
En savoir plus
Lysa
2022_LYSA_Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
Hemasphere . 2022 Jan 10;6(2):e672.
En savoir plus
Lysa
2022_LYSA_Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
Ann Hematol . 2022 Feb;101(2):317-332.
En savoir plus
Lysa
2022_LYSA_Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group
Cancers (Basel) 2022 Mar 30;14(7):1761. doi: 10.3390/cancers14071761.
En savoir plus
Lysa
2022_LYSA_Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study
Cancer . 2022 Feb 1;128(3):519-528. doi: 10.1002/cncr.33938.
En savoir plus
Lysa
2022_LYSA_Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
J Clin Oncol . 2022 Jan 20;40(3):242-251. doi: 10.1200/JCO.21.01815.
En savoir plus
Lysa
2022_LYSA_Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
N Engl J Med . 2022 Jan 27;386(4):351-363. doi: 10.1056/NEJMoa2115304.
En savoir plus
Lysa
2022_LYSA_Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study
J Clin Oncol 2022 Jan 6;JCO2101777. doi: 10.1200/JCO.21.01777
En savoir plus